These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 16163229

  • 21. [Rare clinical forms of multiple myeloma].
    Golenkov AK.
    Ter Arkh; 1994; 66(12):90-2. PubMed ID: 7900059
    [Abstract] [Full Text] [Related]

  • 22. A case of IgM paraproteinemia in which serum free light chain values were within reference intervals.
    Ma ES, Lee ET.
    Clin Chem; 2007 Feb; 53(2):362-3. PubMed ID: 17259251
    [No Abstract] [Full Text] [Related]

  • 23. Removal and recovery rate of paraproteins by plasma exchange.
    Busnach G, Perrino ML, Dal Col A, Brando B, Minetti L.
    Life Support Syst; 1983 Feb; 1 Suppl 1():112-4. PubMed ID: 6443836
    [No Abstract] [Full Text] [Related]

  • 24. Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
    Huston A, Brown J, Roodman GD.
    Exp Hematol; 2006 Dec; 34(12):1616. PubMed ID: 17157156
    [No Abstract] [Full Text] [Related]

  • 25. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
    Kyrtsonis MC, Vassilakopoulos TP, Kafasi N, Sachanas S, Tzenou T, Papadogiannis A, Galanis Z, Kalpadakis C, Dimou M, Kyriakou E, Angelopoulou MK, Dimopoulou MN, Siakantaris MP, Dimitriadou EM, Kokoris SI, Panayiotidis P, Pangalis GA.
    Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
    [Abstract] [Full Text] [Related]

  • 26. Future Directions in the Evaluation and Treatment of Precursor Plasma Cell Disorders.
    Manier S, Salem KZ, Liu D, Ghobrial IM.
    Am Soc Clin Oncol Educ Book; 2016 May; 35():e400-6. PubMed ID: 27249747
    [Abstract] [Full Text] [Related]

  • 27. [Diagnosis and follow up of patients with small M components. With the view to avoid transformation to malignant disease].
    Turesson I, Westin J.
    Lakartidningen; 2016 May; 107(4):176-9. PubMed ID: 20333970
    [No Abstract] [Full Text] [Related]

  • 28. Familial myeloma.
    Lynch HT, Ferrara K, Barlogie B, Coleman EA, Lynch JF, Weisenburger D, Sanger W, Watson P, Nipper H, Witt V, Thomé S.
    N Engl J Med; 2008 Jul 10; 359(2):152-7. PubMed ID: 18614782
    [Abstract] [Full Text] [Related]

  • 29. [Multiple myeloma with double gammopathy (IgA-kappa, IgA-lambda) : induction of complete remission from plateau phase with interferon-alpha 2a therapy].
    Kanoh T.
    Rinsho Ketsueki; 1996 Apr 10; 37(4):335-9. PubMed ID: 8847805
    [Abstract] [Full Text] [Related]

  • 30. Light-chain paraproteins with lupus anticoagulant activity.
    Yasin Z, Quick D, Thiagarajan P, Spoor D, Caraveo J, Palascak J.
    Am J Hematol; 1999 Oct 10; 62(2):99-102. PubMed ID: 10509004
    [Abstract] [Full Text] [Related]

  • 31. Amyloidosis: clinical pentad.
    Mookadam F, Mookadam M, Jiamsripong P.
    Intern Med J; 2011 Jan 10; 41(1a):66-7. PubMed ID: 21265964
    [No Abstract] [Full Text] [Related]

  • 32. In vivo kinetic studies in human myeloma.
    Pileri A, Tarocco RP.
    Haematologica; 1974 Mar 10; 59(1):10-24. PubMed ID: 4137723
    [No Abstract] [Full Text] [Related]

  • 33. New drugs for multiple myeloma.
    Anderson KC.
    Clin Adv Hematol Oncol; 2006 Aug 10; 4(8):592-4. PubMed ID: 17099617
    [No Abstract] [Full Text] [Related]

  • 34. [Immunoblastic sarcoma in an IgM myeloma with the appearance of a second monoclonal component].
    Juliá A, Zuazu J, Ruiz-Marcellán C.
    Sangre (Barc); 1985 Aug 10; 30(3):355-62. PubMed ID: 3929411
    [No Abstract] [Full Text] [Related]

  • 35. Thalidomide in the treatment of multiple myeloma.
    Kastritis E, Dimopoulos MA.
    Best Pract Res Clin Haematol; 2007 Dec 10; 20(4):681-99. PubMed ID: 18070713
    [Abstract] [Full Text] [Related]

  • 36. Biclonal plasma cell myeloma with the simultaneous appearance of both secretory lambda and nonsecretory kappa monoclonal light chains.
    Gu HJ, Cho SY, Lee J, Sung JY, Park TS.
    Clin Chem Lab Med; 2017 Jan 01; 55(1):e21-e24. PubMed ID: 27442368
    [No Abstract] [Full Text] [Related]

  • 37. Lenalidomide: new drug. Myeloma: many questions remain unanswered.
    Prescrire Int; 2008 Dec 01; 17(98):230-2. PubMed ID: 19422142
    [Abstract] [Full Text] [Related]

  • 38. Novel extended reference range for serum kappa/lambda free light chain ratio in diagnosing monoclonal gammopathies in renal insufficient patients.
    Diamantidis MD, Ioannidou-Papagiannaki E, Ntaios G.
    Clin Biochem; 2009 Jul 01; 42(10-11):1202-3. PubMed ID: 19375413
    [No Abstract] [Full Text] [Related]

  • 39. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
    Sui WW, Yao HJ, Wang YF, Wang L, Zhang K, Xu Y, Qiu LG.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3158-60. PubMed ID: 18269880
    [Abstract] [Full Text] [Related]

  • 40. [Persistent polyclonal B lymphocytosis].
    Velasco-Rodríguez D, Hernández JÁ, Alvarez B, Acedo N.
    Med Clin (Barc); 2014 Jun 06; 142(11):518. PubMed ID: 24725855
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.